Abstract:
Phosphonate nucleotide compounds represented by general formula (I), their salts, hydrates and solvates thereof, and drugs containing the same, wherein R represents C1-6 alkyl, etc.; R represents hydrogen, halogenated C1-4 alkyl, etc.; R represents hydrogen, halogenated C1-4 alkyl, etc.; R represents hydrogen, halogenated C1-4 alkyl, etc.; and X represents carbon or nitrogen. These drugs are useful as antiviral agents for human immunodeficiency virus, herpes simplex virus, hepatitis B virus, etc., and as antitumor agents.
Abstract translation:由通式(I)表示的膦酸酯核苷酸化合物,其盐,水合物和溶剂合物,以及含有该膦酸酯的化合物,其中R 1表示C 1-6烷基等; R 2表示氢,卤代C 1-4烷基等; R 3表示氢,卤代C 1-4烷基等; R 4代表氢,卤代C 1-4烷基等; X表示碳或氮。 这些药物可用作人类免疫缺陷病毒,单纯疱疹病毒,乙型肝炎病毒等的抗病毒剂,以及作为抗肿瘤剂。
Abstract:
There is provided an ICG-loaded polymer nanoparticle that is dynamically stable, prevents the leakage of contained ICG and the resulting discoloration, and has a high molar absorbance coefficient. The particle contains a hydrophilic dye having a sulfonate group and a hydrophobic polymer, and the particle further contains at least one of a lipid having a positively charged region, a nicotinic acid derivative and a thiamine derivative.
Abstract:
An image display panel having, in a multilayer structure, a first (1) and second light (2) modulating layers each comprising a periodical planar arrangement of a plurality of light modulating elements (3, 4) for modulating a color or a brightness of an incident light in response to an input signal, wherein the arrangement period of the light modulating element in the first light modulating layer (3) is smaller than the arrangement period of the light modulating element in the second light modulating layer (4).
Abstract:
The object of the present invention is to detect and identify a medicament which inhibits activation of viral polymerase via RNA binding, and also to provide an anti-viral agent using a medicament which inhibits activation of viral polymerase via RNA binding. The present invention provides an anti-viral agent comprising, as an active ingredient, a medicament which inhibits activation of viral polymerase via RNA binding.
Abstract:
An image display panel having, in a multilayer structure, a first and second light modulating layers each comprising a periodical planar arrangement of a plurality of light modulating elements for modulating a color or a brightness of an incident light in response to an input signal, wherein the arrangement period of the light modulating element in the first light modulating layer is smaller than the arrangement period of the light modulating element in the second light modulating layer.
Abstract:
A compound represented by general formula (I) and having an antiviral activity, wherein R represents hydrogen, C1-6 alkyl or C7-10 aralkyl; R represents C1-6 alkyl, C7-10 aralkyl or phenyl; R and R independently represent each hydrogen, C1-6 alkyl, acyloxymethyl, acylthioethyl or ethyl substituted by at least one halogen atom; R represents hydrogen, C1-4 alkyl, C1-4 hydroxyalkyl or C1-4 alkyl substituted by at least one halogen atom; and X represents carbon or nitrogen.
Abstract translation:由通式(I)表示并具有抗病毒活性的化合物,其中R 1表示氢,C 1-6烷基或C 7-10芳烷基; R 2表示C 1-6烷基,C 7-10芳烷基或苯基; R 3和R 4独立地表示氢,C 1-6烷基,酰氧基甲基,酰硫基乙基或被至少一个卤素原子取代的乙基; R 5表示氢,C 1-4烷基,C 1-4羟基烷基或被至少一个卤素原子取代的C 1-4烷基; X表示碳或氮。